Author(s): Kazunori Murai, Shinya Kimura, Jun Imagawa, et. al. EHA Library. MURAI K. Jun 14, 2019; 266207; PF407 Abstract: PF407 Session topic: 8. Chronic myeloid leukemia – Clinical Background The main treatment goal for patients with chronic phase chronic myelogenous leukemia (CML-CP) is discontinuation of tyrosine kinase inhibitor (TKI) therapy. In the...
Pro zobrazení tohoto obsahu je třeba být přihlášen.